Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-06-26T01:08:33.945Z Has data issue: false hasContentIssue false

A Cluster of Fever and Hypotension on a Surgical Intensive Care Unit Related to the Contamination of Plasma Expanders by Cell Wall Products of Bacillus stearothermophilus

Published online by Cambridge University Press:  02 January 2015

Antoni Trilla*
Affiliation:
Infection Control Program, Infectious Diseases Unit, Microbiology Laboratory, Hefiatology Unit, Cardiac Surgery Unit, Department of Pharmacy, and Quality Assurance Committee, Hospital Clinic, University of Barcelona, Spain
Carles Codina
Affiliation:
Infection Control Program, Infectious Diseases Unit, Microbiology Laboratory, Hefiatology Unit, Cardiac Surgery Unit, Department of Pharmacy, and Quality Assurance Committee, Hospital Clinic, University of Barcelona, Spain
Montserrat Salles
Affiliation:
Infection Control Program, Infectious Diseases Unit, Microbiology Laboratory, Hefiatology Unit, Cardiac Surgery Unit, Department of Pharmacy, and Quality Assurance Committee, Hospital Clinic, University of Barcelona, Spain
Josep M. Gatell
Affiliation:
Infection Control Program, Infectious Diseases Unit, Microbiology Laboratory, Hefiatology Unit, Cardiac Surgery Unit, Department of Pharmacy, and Quality Assurance Committee, Hospital Clinic, University of Barcelona, Spain
Magda Zaragoza
Affiliation:
Infection Control Program, Infectious Diseases Unit, Microbiology Laboratory, Hefiatology Unit, Cardiac Surgery Unit, Department of Pharmacy, and Quality Assurance Committee, Hospital Clinic, University of Barcelona, Spain
Francesc Marco
Affiliation:
Infection Control Program, Infectious Diseases Unit, Microbiology Laboratory, Hefiatology Unit, Cardiac Surgery Unit, Department of Pharmacy, and Quality Assurance Committee, Hospital Clinic, University of Barcelona, Spain
Miquel Navasa
Affiliation:
Infection Control Program, Infectious Diseases Unit, Microbiology Laboratory, Hefiatology Unit, Cardiac Surgery Unit, Department of Pharmacy, and Quality Assurance Committee, Hospital Clinic, University of Barcelona, Spain
Jaume Mulet
Affiliation:
Infection Control Program, Infectious Diseases Unit, Microbiology Laboratory, Hefiatology Unit, Cardiac Surgery Unit, Department of Pharmacy, and Quality Assurance Committee, Hospital Clinic, University of Barcelona, Spain
Josep Ribas
Affiliation:
Infection Control Program, Infectious Diseases Unit, Microbiology Laboratory, Hefiatology Unit, Cardiac Surgery Unit, Department of Pharmacy, and Quality Assurance Committee, Hospital Clinic, University of Barcelona, Spain
Maria T. Jimenez de Anta
Affiliation:
Infection Control Program, Infectious Diseases Unit, Microbiology Laboratory, Hefiatology Unit, Cardiac Surgery Unit, Department of Pharmacy, and Quality Assurance Committee, Hospital Clinic, University of Barcelona, Spain
Miguel A. Asenjo
Affiliation:
Infection Control Program, Infectious Diseases Unit, Microbiology Laboratory, Hefiatology Unit, Cardiac Surgery Unit, Department of Pharmacy, and Quality Assurance Committee, Hospital Clinic, University of Barcelona, Spain
*
Infection Control Program, Hospital Clinic, Villarroel 170, 08036-Barcelona, Spain

Abstract

Objective:

To evaluate an outbreak of fever and hypotension after cardiac surgical procedures and the role of polygeline, a plasma expander.

Design:

Unmatched case-control study.

Setting:

A six-bed cardiac surgery intensive care unit (SICU) of the Hospital Clinic of Barcelona (Spain), a 940-bed public teaching hospital.

Patients:

Eight cases and 25 control patients admitted to the SICU over a 4-week epidemic period.

Main Outcome Measures:

Development of hypotension (systolic blood pressure ≤ 90 mm Hg or a drop of 40 mm Hg from baseline systolic blood pressure) and fever (axillary temperature >38.5°C) within 24 hours of a cardiac surgical procedure.

Results:

The single risk factor significantly different between cases and controls was the total volume of polygeline used throughout the surgical procedure for extracorporeal circulation: a median of 1,250 mL (mean, 1,312.5 ± 842.5 mL) in cases versus 500 mL (mean, 566.0 ± 159.9 mL) in controls (P = .0029). By multiple logistic regression analysis, polygeline use was the single risk factor significantly related to the outcome (odds ratio, 8.75; CI95, 1.36 to 56.2; P= .01). Neither blood cultures from patients nor cultures of the polygeline used yielded growth of any microorganism. Stopping use of the implicated polygeline lot controlled the outbreak.

Conclusions:

Use of polygeline was associated with an outbreak of fever and hypotension in a SICU. Information from the manufacturer indicated the likelihood of contamination of the product with Bacillus stearothermophilus components. The manufacturer has since changed the production and control processes, and no further adverse events have been seen.

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Freeman, MK. Fatal reaction to haemaccel. Anesthesis 1979;34:341343.Google Scholar
2. Barrat, S, Purcell, GJ. Refractory bronchospasm following haemaccel infusion and bupivacaine epideural anesthesia. Anaesth Intensive Care 1988;16:208211.CrossRefGoogle Scholar
3. Jurado, AS, Piheiro, TJ, Madeira, VM. Physical studies on membrane lipids of Bacillus stearothemophilus temperature and calcium effects. Arch Biochem Biophys 1991;289:167179.Google Scholar
4. Breitwieser, A, Gruber, K, Sleytr, UB. Evidence for an S-layer protein pool in the peptidoglycan of Bacillus stearothemophilus . J Bacteriol 1992;174:80088015.Google Scholar
5. Forrest, TM, Wilson, GE, Pan, Y, Schaefer, J. Characterization of cross-linking of cell walls of Bacillus subtilis by a combination of magic-angle spinning NMR and gas chromatography-mass spectrometry of both intect and hydrolyzed 13C and 15N-labeled cell-wall peptidoglycan. J Biol Chem 1991;266:2448524491.Google Scholar
6. Hemila, H. Sequence of a PAL-related lipoprotein from Bacillus subtilis . FEMS Microbial Lett 1991;66:3741.Google Scholar
7. Noble, RC, Reeves, SA. Bacillus species pseudosepsis caused by contaminated commercial blood culture media. JAMA 1974;230:10021004.CrossRefGoogle ScholarPubMed
8. Berger, SA. Pseudobacteremia due to contaminated alcohol swabs. J Clin Microbiol 1983:18:974975.Google Scholar
9. Gurevich, I, Tafuro, P, Krystofiak, SP, Kalter, RD, Cunha, BA. Three clusters of Bacillus pseudobacteremia related to a radiometric blood culture analyzer. Infect Control 1984;5:7174.Google Scholar
10. Centers for Disease Control. Bacterial contamination of platelet pools—Ohio, 1991. MMWR 1992;41:3637.Google Scholar
11. Goldstein, B, Abrutyn, E. Pseudo-outbreak of Bacillus species related to fiberoptic bronchoscopy. J. Hosp Infect 1985;6:194200.Google Scholar
12. Richardson, AJ, Rothburn, MN, Roberts, C. Pseudo-outbreak of Bacillus species related to fiberoptic bronchoscopy. J Hosp Infect 1986;7:208210.CrossRefGoogle Scholar
13. LeHau, LA, Benjamin, D, Cantrell, HE Potts, DW, Boggs, JM. Bacillus species pseudomeningitis. Infect Control Hosp Epidemiol 1989;9:394397.Google Scholar
14. Bryce, EA, Smith, JA, Tweeddale, M, Andruschak, BJ, Maxwell, MR Dissemination of Bacillus cereus in an intensive care unit. Infect Control Hosp Epidemiol 1993;14:459462.Google Scholar